Welcome to our dedicated page for SEMPRA SEC filings (Ticker: SREA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SEMPRA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SEMPRA's regulatory disclosures and financial reporting.
Kevin C. Sagara, a director of Sempra, reported changes in his deferred equity-based compensation on a Form 4. The filing details phantom shares of Sempra common stock held under the company’s deferred compensation and director compensation programs.
On 01/02/2026, phantom share transactions were reported at prices of $88.95 and $89.71 per share, each representing a right tied on a 1-for-1 basis to Sempra common stock. Following these transactions, Sagara beneficially owned 3,621.32 phantom shares in total.
The phantom shares are payable in cash and may be reallocated into alternative investment accounts. The total includes 2,044.10 unvested restricted phantom shares, which are subject to forfeiture if his service as a director ends before vesting, other than in cases of death, disability, or removal without cause.
Sempra director reports phantom stock compensation
Michael N. Mears, a director of Sempra, reported receiving 139.34 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These derivative securities have a conversion rate of 1-for-1 into Sempra common stock and are immediately exercisable for vested shares, with no stated expiration date.
After this transaction, Mears beneficially owns a total of 20,517.13 phantom shares. This total includes 1,892.82 unvested restricted phantom shares that may be forfeited if his service as a director ends before vesting, except in cases of death, disability, or removal without cause.
Sempra director reports grant of phantom stock units as compensation. Director Richard J. Mark filed a Form 4 showing he acquired 139.34 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These are derivative securities that track the value of Sempra common stock and are convertible into common stock on a 1-for-1 basis. The filing states the phantom shares are immediately exercisable for vested shares and have no expiration date. Following this transaction, Mark beneficially owned 1,717.71 phantom shares, held in direct ownership form.
Sempra director reports phantom stock grant as compensation
Sempra director Jennifer M. Kirk reported receiving 139.34 phantom shares of Sempra common stock on 01/02/2026 as part of her director compensation. These phantom shares are convertible into Sempra common stock on a 1-for-1 basis, with the transaction price noted as $89.71 per share. Following this grant, she beneficially owns a total of 4,672.31 phantom shares.
The total includes 1,892.82 unvested restricted phantom shares that may be forfeited if her service as a director ends before vesting, except in cases of death, disability, or removal without cause. The phantom shares that have vested are immediately exercisable, and no expiration date applies.
Sempra director Pablo A. Ferrero reported receiving derivative equity compensation tied to the company’s common stock. On 01/02/2026, he acquired 139.34 phantom shares of Sempra common stock as director compensation at a price of $89.71 per phantom share.
Each phantom share converts into Sempra common stock on a 1-for-1 basis, and the shares that have vested are immediately exercisable. Following this transaction, Ferrero beneficially owned 15,774.13 phantom shares in total in direct form, with no stated expiration date for these derivative interests.
Sempra director Andres Conesa reported receiving phantom stock as compensation. On 01/02/2026, he acquired 139.34 phantom shares of Sempra common stock as director compensation at a reference price of $89.71 per share. Each phantom share is convertible into one share of Sempra common stock. After this transaction, he beneficially owns 11,310.11 derivative securities in the form of phantom shares, held in direct ownership. The phantom shares are immediately exercisable for vested amounts and have no stated expiration date.
Sempra insider files notice to sell common stock under Rule 144. The filing covers a proposed sale of 30,000 shares of Sempra common stock through Oppenheimer & Co. on the NYSE, with an indicated aggregate market value of $2,648,700. These shares were acquired on 02/19/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan as equity compensation. The filing notes that the person signing the notice represents they are not aware of undisclosed material adverse information about Sempra's current or prospective operations.
Sempra (SRE) filed a notice under Rule 144 for a planned sale of 7,564 shares of its common stock through Oppenheimer & Co. on the NYSE, with an aggregate market value of $699,670. The filing notes that 652,681,521 shares of Sempra common stock were outstanding. The shares to be sold were acquired via vesting of restricted stock units under Sempra's Long-Term Incentive Plan, including 2,325 shares vested on 01/02/2025, 1,000 shares vested on 01/28/2025, and 4,239 shares vested on 02/19/2025, all received as equity compensation.
A Sempra shareholder filed a Form 144 notice to sell 1,510 shares of Sempra common stock through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $138,316.00. These shares relate to the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan on 01/03/2022, received as compensation and vesting on the same date. Shares outstanding were 652,681,521; this is a baseline figure, not the amount being sold.
Sempra (SRE) filed a Form 144 indicating an insider’s planned sale of common stock. The notice covers a proposed sale of 500 shares of common stock through broker Oppenheimer & Co., Inc. on the NYSE, with an indicated aggregate market value of $45,800.00. The filing states that there were 652,681,521 shares of Sempra common stock outstanding at the time of the notice.
The 500 shares to be sold were acquired on 01/28/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan as compensation. The same insider previously sold 5,500 shares of Sempra common stock on 11/18/2025 for gross proceeds of $503,696.00.